Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis.
Vorselaars AD, Crommelin HA, Deneer VH, Meek B, Claessen AM, Keijsers RG, van Moorsel CH, Grutters JC. Vorselaars AD, et al. Among authors: meek b. Eur Respir J. 2015 Jul;46(1):175-85. doi: 10.1183/09031936.00227014. Epub 2015 Apr 30. Eur Respir J. 2015. PMID: 25929955 Free article.
Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?
Hijdra D, Vorselaars AD, Crommelin HA, van Moorsel CH, Meek B, Claessen AM, Rijkers GT, Grutters JC. Hijdra D, et al. Among authors: meek b. Eur Respir J. 2016 Oct;48(4):1242-1245. doi: 10.1183/13993003.00709-2016. Epub 2016 Jul 7. Eur Respir J. 2016. PMID: 27390275 Free article. No abstract available.
Etiology and Immunopathogenesis of Sarcoidosis: Novel Insights.
Beijer E, Veltkamp M, Meek B, Moller DR. Beijer E, et al. Among authors: meek b. Semin Respir Crit Care Med. 2017 Aug;38(4):404-416. doi: 10.1055/s-0037-1603087. Epub 2017 Jul 27. Semin Respir Crit Care Med. 2017. PMID: 28750457 Review. No abstract available.
Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis.
Spoorenberg SMC, Vestjens SMT, Voorn GP, van Moorsel CHM, Meek B, Zanen P, Rijkers GT, Bos WJW, Grutters JC; Ovidius study group. Spoorenberg SMC, et al. Among authors: meek b. PLoS One. 2018 Jan 11;13(1):e0190575. doi: 10.1371/journal.pone.0190575. eCollection 2018. PLoS One. 2018. PMID: 29324810 Free PMC article.
125 results